Skip to main content
Clinical Trials/NCT05650151
NCT05650151Not yet recruitingNot Applicable

Peri-operative Vitamin D Therapy for Patients With Hepatocellular Carcinoma Receiving Hepatectomy

National Taiwan University Hospital0 sites200 target enrollmentStarted: January 1, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
200
Primary Endpoint
Infection rate

Study Overview

Brief Summary

The goal of this double-blind, randomized controlled trial is to test the effect of short-term and high-dose vitamin D therapy in patients undergoing hepatectomy for hepatocellular carcinoma.

Detailed Description

Participants will receive short-term high dose of vitamin D during perioperative period.

The main questions the study aims to answer are:

  1. If vitamin D therapy benefits perioperative care
  2. If short-term high dose of vitamin D supplement is safe

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients older than 20 years
  • •Patients will undergo hepatectomy for hepatocellular carcinoma.

Exclusion Criteria

  • •Patients with hypercalcemia, hyperparathyroidism, sarcoidosis, multiple myeloma

Arms & Interventions

Vitamin D group

Experimental

Intervention: Vitamin D (Dietary Supplement)

Control group

Placebo Comparator

Intervention: Placebo (Dietary Supplement)

Outcomes

Primary Outcomes

Infection rate

Time Frame: Perioperative period

Diagnosed by clinical presentation and relevant biomarker

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials